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a  b  s  t  r  a  c  t
Flephedrone  (4-ﬂuoromethcathinone,  4-FMC)  was  analysed  using 1H, 13C, 15N HMBC,  and 19F  observe
spectroscopy,  gas  chromatography-ﬂame  ionisation  detection  (GC-FID),  and  electrospray  ionisation-
mass  spectrometry  (ESI-MS).  Analysis  of  four  4-FMC  samples  (from  a Bristol  nightclub  in  2013)  showed
that  they  all  contained  benzocaine  as  the  cutting  agent  present  in different  amounts  from  5 to  12%. Using
these  methods,  we  successfully  differentiated  between  ﬂephedrone  regioisomers  and  mephedrone  in  an
analytical  method  validated  for ﬂephedrone  as a substituted  cathinone.  The  data  show  that  these  noweywords:
mnesty bin
enzocaine
athinone
illegal  cathinone-derived  stimulants  (highs)  are  now  being  cut;  users  cannot  be  certain  of  the purity  of
the drug  they  are  taking.  Furthermore,  there  are  risks  from  the pharmaceutically  active  cutting  agents
themselves.
© 2014  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND
utting agent
ephedrone
. Introduction
The close similarity between cathinone derivatives (Fig. 1)
akes the speciﬁc identiﬁcation of these drugs and their regioi-
omers challenging and could lead to mislabelling or accidental
isidentiﬁcation or deliberate deception as in the nature of the cut-
ing of illicit (street) drugs. Flephedrone (4-ﬂuoromethcathinone,
-FMC) (Fig. 1c) was ﬁrst synthesised in 1952, but surprisingly there
s a paucity of published data for this compound. Compared with
athinone (Fig. 1a) and mephedrone (4-methylmethcathinone, 4-
MC) (Fig. 1b), the C F bond on the aromatic ring of 4-FMC (Fig. 1c)
as a speciﬁc polarity effect. This may  inﬂuence receptor binding
nd therefore inﬂuence the biological activity [1,2]. The biological
ffects of cathinone ring-substituted derivatives are claimed to be
imilar to cocaine, amphetamine, or MDMA  (ecstasy) [3]. In the UK,
 question about a decrease in the purity of cathinones has arisen
fter they were banned as Class B drugs under the Misuse of Drugs
ct in April 2010 [4].
As a routine analytical technique, e.g. used by the police,
C–MS [5–7] or GC-FID [6], infrared (FT-IR) [7], and RamanPlease cite this article in press as: M.R. Alotaibi, et al., 1H, 13C, 15N
ﬂephedrone, cut with benzocaine, J. Pharm. Biomed. Anal. (2015), http
pectroscopy are widely used for the detection of controlled
ubstances [8]. Nevertheless, standard reference materials for
etecting what may  be present in unknown samples are required.
∗ Corresponding author. Tel.: +44 01225 386795; fax: +44 01225 386114.
E-mail address: prsisb@bath.ac.uk (I.S. Blagbrough).
ttp://dx.doi.org/10.1016/j.jpba.2014.12.033
731-7085/© 2014 The Authors. Published by Elsevier B.V. This is an open access article unlicense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Using GC–MS alone would potentially not distinguish between
the 2-, 3-, and 4-regioisomers of FMC, all the isomers having
been reported in elegant synthetic work with full characterisa-
tion by Archer [7]. Electron impact-mass spectrometry (EI-MS)
also leads to uncertainty in distinguishing between ﬂephedrone
isomers [7]. More recently, screening methods for the detec-
tion of new (illicit) psychoactive drugs in urine were reported
that use liquid chromatography coupled with tandem mass spec-
trometry (LC–MS/MS) [9], HPLC [6], and ultra performance liquid
chromatography–quadrupole time-of-ﬂight-mass spectrometry
(UPLC–QTOF-MS) [5].
NMR  spectroscopy is an established analytical tool for the iden-
tiﬁcation of controlled substances without the need for sample
derivatisation or the need to remove any impurity. Also, dis-
tinguishing between regioisomers, between salt and free base,
determining percentage purity and impurity ratios are successfully
and rapidly achieved using NMR  spectroscopy. Police or forensic
intelligence information may  be gained from this kind of analysis
to aid law enforcement. The aim of this work is to develop a robust,
rapid, and quantitative analytical approach to detect ﬂephedrone
as well as the impurities (cutting agents) present in street sam-
ples using 1H, 13C, 15N, and 19F NMR  spectroscopy together with
GC. HMBC, and 19F NMR  spectroscopic characterisation of seized
://dx.doi.org/10.1016/j.jpba.2014.12.033
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. (a) Cathinone, (b) m
. Experimental
.1. Chemicals and materials
Four creamy coloured crystal samples, as part of an amnesty
in provided in a (Bristol, UK) nightclub, in 2013, were identiﬁed
s ﬂephedrone. A reference standard of ﬂephedrone hydrochloride
alt (4-FMC HCl) was purchased from LGC Standards, UK. An ana-
ytical standard of mephedrone hydrochloride salt (4-MMC  HCl)
as purchased from Aldrich, UK. Deuterium oxide (99.8 atom % D,
ldrich, UK), per-deuteriated methanol (99.8 atom % D, Cambridge
sotope Laboratories, USA), and all other solvents were of HPLC
rade, ≥99.9% purity (Aldrich, UK). Benzocaine B.P. was purchased
rom J. M.  Loveridge plc (Southampton, UK).
.2. Experimental procedures and instrumentation
Each sample of ﬂephedrone (4-FMC) was weighed, dissolved,
nd analysed at 20–25 ◦C without any puriﬁcation. NMR  spectra
ere recorded on Bruker 400 or 500 MHz  spectrometers, referen-
ed to external Me4Si and/or via residual protons in the deuteriated
olvents. Samples (∼30 mg  each) were vortexed for 2 min  in D2O
0.6 mL). Identiﬁcation of ﬂephedrone samples and their impuri-
ies followed NMR  analysis including: 1H, 13C, 15N (HMBC), HSQC,
MBC, and COSY. A GC method was optimised to analyse authentic
-FMC nightclub samples dissolved in methanol (50 mg/mL), and
enzocaine B.P. injected directly into the GC-FID without any prior
hemical derivatisation. GC separation was performed on a CP-
003 (Chrompack, Middelburg, The Netherlands) using a capillary
olumn ZB-WAX (polyethylene glycol, 10 m × 0.25 mm × 0.25 m,
henomenex, UK). An injection volume (1–2 L) was carried by
elium carrier gas at a ﬂow rate of 23–27 mL/s. The oven tem-
erature was programmed with 250 ◦C injector and detector
emperature, 110 ◦C (2 min) oven initial and 230 ◦C (4 min) ﬁnal
emperatures with 40 ◦C/min rate of heating, total run time was
 min. Positive ion [M+H]+ mode LC/MS was performed, on sam-
les dissolved in methanol, using a Bruker Daltonics micrOTOF
ass spectrometer equipped with an electrospray ionisation (ESI)
ource.
. Results and discussion
.1. 1H, 13C, 15N, and 19F NMR  spectroscopy
4-FMC NMR  spectra show diagnostic 19F and 1H coupling (Fig. 2)
n the aromatic region; 1H, 13C, and 19F NMR  spectral data are
eported in Table 1. NMR  spectra are discussed and compared
o those of the closely related cathinone derivative mephedrone
-MMC (Table 1, Fig. 2). The structures were conﬁrmed by com-
aring the NMR  data with those of an authentic sample of 4-FMC
nd the literature values [7], establishing the regioisomer as para-
ubstituted. Unfortunately, two lines in the literature 13C NMR
pectroscopic assignment Table have been transposed [7], and thePlease cite this article in press as: M.R. Alotaibi, et al., 1H, 13C, 15N
ﬂephedrone, cut with benzocaine, J. Pharm. Biomed. Anal. (2015), http
orrect aromatic region assignment is given in Table 1 for  116
d, 2JCF 22 Hz) and 132 (d, 3JCF 10 Hz) ppm, where the coupling
onstants are diagnostic for ortho to F (C3, C5) and meta to F (C2,
6) respectively.F c
rone, and (c) ﬂephedrone.
While the 1H NMR  spectrum of 4-FMC is similar to that of 4-
MMC  (Fig. 2), the absence of a 4-methyl aromatic substituent peak,
and the coupling from the 19F atom are diagnostic. The 13C-19F split-
ting patterns around the entire aromatic ring (e.g. 167 ppm, d, 1JCF
255 Hz; 129 ppm, d, 4JCF 3 Hz) in the 13C spectra (Table 1) are also
signiﬁcant. 15N NMR  HMBC was  run to detect the number, kind,
and position of the nitrogen atoms proving the presence of a sec-
ondary amine coupled to the two N- and -methyl groups (Fig. 3).
19F NMR  spectroscopy proves the presence and position of a ﬂuo-
rine atom in such samples. Comparing with the literature data [7],
the 19F NMR  chemical shift values for the each of the four 4-FMC
samples show para-substitution: 19F NMR  showed −102.1 ppm (tt,
3JHF 8.4 Hz, 4JHF 5.2 Hz) (Fig. 3) with the d 1JCF 255 Hz easily visible
only in the 13C NMR  spectrum, not in the 19F NMR  spectrum due to
the low (1.1%) 13C natural abundance.
3.2. ESI-MS and impurity proﬁling
The ESI-MS gave [M+H]+ at 182.0976 and 182.1006 for the
samples and the authentic hydrochloride salt of ﬂephedrone
respectively, C10H13FNO requires 182.0981 thus conﬁrming
the identity of a regioisomer of ﬂephedrone. ESI-MS spec-
tra also gave [M+H]+ 166.0874. Benzocaine C9H12NO2 [M+H]+
requires 166.0868; [M+Na]+ C9H11NO2Na found 188.0689, requires
188.0687.
Analysis of the 4-FMC samples by NMR  and ESI-MS showed that
they were impure. The 1H and 13C NMR  data of the impurity are:
1H NMR  (D2O): ı 1.36 (t, 3JHH 7 Hz), 4.33 (q, 3JHH 7 Hz), 6.83 (H3
and H5, t, 3JHH 7.6 Hz), 7.86 (H2 and H6, d, 3JHH 7.6 Hz) [10]; 13C
NMR  (D2O): ı 15 (C7), 61 (C6), 114 (C3, C5), 119 (C1), 132 (C2, C6),
155 (C4), 169 (C5) ppm [11]. A GC-FID method was then developed
to resolve ﬂephedrone and benzocaine in mixed samples, achieved
with retention times of Rt = 2.8 min  and 4.9 min respectively (Fig. 4).
The benzocaine levels in these 4-FMC samples were quantiﬁed by
GC (5, 6, 7, and 12%), impurity levels which are in agreement with
those determined from the (more approximate) 1H NMR  integra-
tion data, 4, 6, 7, and 10%. Benzocaine has previously also been
quantiﬁed by HPLC [12].
4-FMC is a designed cathinone derivative either designed to
side-step the banning of the legal high 4-MMC  and/or with one
eye on the potential pharmacological enhancement from incorpo-
rating a ﬂuorine substituent in a biologically active small molecule
as “there is also evidence that single, carbon-bound ﬂuorine sub-
stituents, particularly when on an aromatic ring, can exhibit speciﬁc
polarity inﬂuences, including H-bonding, that can strongly inﬂu-
ence binding” [1]. The human toxicology of ﬂephedrone is not well
established [13]. Lipophilicity is signiﬁcant as it often controls the
absorption, transport, or receptor binding of a compound and so
can enhance its bioavailability. The effect on the lipophilicity of
ﬂuorine substituents on an aromatic ring was calculated by Dolbier
showing that CF3 (x = 0.88) is greater than CH3 (x = 0.56) follow-
ing from the respective n-octanol/water partition coefﬁcients [1].
So, perhaps counter-intuitively, the presence of the most powerful HMBC, and 19F NMR  spectroscopic characterisation of seized
://dx.doi.org/10.1016/j.jpba.2014.12.033
electronegative atom, a ﬂuorine substituent, gives rise to enhanced
lipophilicity.
Benzocaine is a well-known topical anaesthetic. However,
the FDA has reported that using a gel or spray containing
ARTICLE IN PRESSG ModelPBA-9872; No. of Pages 4
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Fig. 2. 1H NMR  of mephedrone (left) and ﬂephedrone (right) (D2O) with aromatic region expansion showing 19F couplings and the ∼7% benzocaine signals here are clearly
visible.
Table 1
1H (400 MHz), 13C (100 MHz), and 19F (470 MHz) spectral data of ﬂephedrone (D2O).
Position Flephedrone Mephedrone
1H 13C 19F 1H 13C
1 – 129 (d, 4JCF 3 Hz) – 129.7
2,6  8.07 (dd, 3JHH 8.4 Hz, 4JHF 5.2 Hz) 132 (d, 3JCF 10 Hz) 7.96 (d, 3JHH 8 Hz) 129.1
3,5  7.31 (t, 3JHH = 3JHF 8.4 Hz) 116 (d, 2JCF 22 Hz) 7.48 (d, 3JHH 8 Hz) 129.9
4  – 167 (d, 1JCF 255 Hz) –102.1, tt, 3J 8.4, 4J 5.2 Hz – 147
7  – 196 – 197
8  5.09 (q, 3JHH 7 Hz) 60 5.11 (q, 3JHH 7 Hz) 60
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(9  1.60 (d, JHH 7 Hz) 15 
N-CH3 2.81, s 31 
4-Me  – – 
enzocaine could cause a serious blood disorder, methemoglobine-
ia  [14,15]. Similar concerns are raised elsewhere, e.g. Taleb and
o-workers review the evidence where even following topical
pplication of benzocaine, oxidised haemoglobin might increase
ausing methemoglobinemia [16]. Even more recently, a few weeks
go, a case of acquired methemoglobinemia due to the frequent
se of the legal high “Pink Panthers” was reported in parallel with
he increasing prevalence of legal highs particularly those contain-
ng added benzocaine [17]. Benzocaine is currently being used inPlease cite this article in press as: M.R. Alotaibi, et al., 1H, 13C, 15N
ﬂephedrone, cut with benzocaine, J. Pharm. Biomed. Anal. (2015), http
he illicit drug market as a common adulterant (cutting agent) to
ncrease proﬁt [18], indeed it is now commonly found in cocaine
ydrochloride [18–20], which might link the supply of such adul-
erated ﬂephedrone to that of other commonly cut illicit drugs.
ig. 3. 15N-HMBC (500 MHz) spectrum of ﬂephedrone (D2O) (left) showing two 15N–1H cou
D2O) (right) (in the presence of ∼7% benzocaine).1.64 (d, JHH 7 Hz) 15
2.84, s 31
2.48, s 21
Drug dealers may  use benzocaine as it is easily accessible and
similar in physical appearance to ﬂephedrone. In sufﬁcient quan-
tity, benzocaine might be added to ﬂephedrone in order to mimic
the initial numbing (anaesthetic) effect of cocaine [21] and possibly
even to sell the mixture not as ﬂephedrone but as cocaine.
Our rapid analysis and quantiﬁcation of 4-FMC and benzocaine
compare well with the literature methods [7,12]. Research is also
on-going to replace aspects of wet-chemistry based quantitative
analysis on minimal trace amounts of illegal drugs with rapid HMBC, and 19F NMR  spectroscopic characterisation of seized
://dx.doi.org/10.1016/j.jpba.2014.12.033
in situ (e.g. potentially on-site analysis in a nightclub) screening
using handheld (therefore portable) spectrophotometers [22,23].
The use of Raman spectroscopy to detect counterfeit medicines
[22] may  be extended to the analysis of street drugs [23], whilst
plings (with peak assignments) and 19F NMR  spectrum (1H coupled) of ﬂephedrone
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iscrimination between simple drug mixtures has been achieved
sing a deep ultraviolet-visible (DUV–vis) reﬂected optical ﬁbre
ensor [24]. Both techniques can detect and possibly quantify
nown drugs for which standard spectra are available, but are not
uitable for the analysis of new drugs.
. Conclusions
The combination of 1H, 13C, 15N, and 19F NMR  spectroscopy was
sed to identify and decipher between ﬂephedrone regioisomers
nd other cathinones such as mephedrone. We  have separated
ephedrone and benzocaine with base-line resolution by GC-FID
nd quantiﬁed the amount of benzocaine adulterant in the four
nightclub) ﬂephedrone samples by GC, the 1H NMR  integration
as in broad agreement. These data show that this now illegal
athinone-derived stimulant (a high) is now being cut by 5–12%
ith benzocaine, so drug users cannot be certain of the purity of
he drug they are taking. Benzocaine as an adulterant can cause seri-
us health problems, potentially more harmful than ﬂephedrone.
herefore, there are risks from the pharmaceutically active cutting
gents themselves.
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